Management
Profile of Board Member
President & CEO
Komei Fukushima, Ph.D.
| 1988-2014 | Eisai Co. Ltd. / Pharmaceutical company |
|---|---|
| 2006-2010 | Eisai Research Institute of Boston Inc. US |
| 2014 | Early Retirement, Eisai |
| 2014-2015 | Lecturer, Department of physiology, Keio University School of Medicine |
| 2014-2020 | PHARMA Consulting, Inc., President & CEO |
| 2015-present | Project Associate Professor, Department of physiology, Keio University School of medicine |
| 2016-present | K Pharma, Inc., President & CEO |
| 1999 | Ph.D., Graduate School of Biosphere Science, Hiroshima University |
| 2020 | MBA, Graduate School of Business Administration, Keio University |
Outside Director
Hideyuki Okano, M.D., Ph.D.
| 1983 | M.D. Keio University School of Medicine |
|---|---|
| 1988 | Ph.D. (Dr. of Medical Science), Keio University |
| 1982-1989 | Instructor, Institute for Protein Research, Osaka University |
| 1989-1993 | Postdoctoral Research Fellow, Department of Biological Chemistry, The Johns Hopkins University School of Medicine. |
| 1992-1994 | Instructor, Institute of Medical Science, University of Tokyo |
| 1994-1997 | Professor, Institute of Basic Medical Sciences, University of Tsukuba |
| 1997-2001 | Professor, Division of Neuroanatomy, Osaka University Graduate School of Medicine |
| 2001-Present | Professor, Department of Physiology, Keio University School of Medicine |
| 2007-2015 | Chair, Graduate School of Medicine, Keio University |
| 2008-Present | University of Queensland Honorary Professor in the Queenland Brain Institute |
| 2009-Present | University of New South Wales Visiting Professor |
| 2015-2017 | Dean, Keio University School of Medicine |
| 2017-Present | Dean, Keio University Graduate School of Medicine |
Masaya Nakamura, M.D., Ph.D.
| 1987 | M.D. Keio University School of Medicine, Orthopedic Surgery |
|---|---|
| 1995 | Ph.D. Keio University School of Medicine, Orthopedic Surgery Neuroscience |
| 1987-1993 | Resident, Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan |
| 1993-1994 | Fellow, Spine and Spinal Cord Surgery, Department of Orthopedic Surgery, Keio University School of Medicine |
| 1998-2000 | Research fellow, Georgetown University, Department of Neuroscience, Washington, D. C., United States |
| 2004-2011 | Assistant professor, Chief of Spinal cord division, Department of Orthopedic Surgery, Keio University School of Medicine |
| 2012- 2014 | Associate professor, Chief of Spinal cord division, Department of Orthopedic Surgery, Keio University School of Medicine |
| 2015-present | Professor & Chair, Department of Orthopedic Surgery, Keio University School of Medicine |
| 2017-present | Vice Dean, Keio University School of Medicine |
Outside Auditor
Yasutaka Nishida
| 2000 | Department of Economics, Shizuoka University |
|---|---|
| 2005-2010 | Ernst & Young ShinNihon LLC |
| 2011 | Public Accountant registration |
| 2012-present | President, Accounting Firm |
Scientific Advisor
Kentaro Yoshimatsu, Ph.D.
| 1978 | M.S., Pharmaceutical Sciences, Tokyo University |
|---|---|
| 1978-2018 | Eisai Co. Ltd. |
| 1991 | Ph.D., Pharmaceutical Sciences, Tokyo University |
| 2003 | R&D Head, Executive Officer, Eisai Co. Ltd. |
| 2006 | R&D Head, Managing Executive Officer, Eisai Co. Ltd. President, Eisai R&D Management Co. Ltd. |
| 2009 | CSO, Managing Executive Officer, Eisai Co. Ltd. |
| 2010 | President, H3 Biomedicine Inc., Cambridge, US |
| 2011 | Senior Scientific Advisor |
| 2018 | Retired from Eisai Co. Ltd. |
| 2018-present | Scientific Advisor, K Pharma Inc. |
| 2018-present | Outside Director, Anaeropharma Science Co. Ltd. |
| 2018-present | President, RIN Institute Inc. |
Atsushi Nakanishi, Ph.D.
| 1986 | Ph.D., Pharmaceutical Sciences, Tokyo University |
|---|---|
| 1986 | Takeda Pharmaceutical Company, Ltd. |
| 1988-1889 | Harvard University, Children’s Hospital |
| 1991 | Principal Scientist, Frontier Research Labs, Takeda |
| 1997 | Associate Director, Frontier Research Labs, Takeda |
| 2001 | Director, Frontier Research Labs, Takeda |
| 2006 | Project Leader, Regenerative Medicine Group, Frontier Research Labs, Takeda |
| 2011 | Director, Biology Research Labs, Takeda |
| 2013 | Director, Shonan Incubation Labs, Takeda |
| 2017 | Director, T-CiRA Research, Regenerative Medicine Unit, Takeda |
| 2018-present | Program Officer, AMED |
| 2020-present | Senior Research Advisor, T-CiRA Discovery, Takeda |
| 2020-present | Scientific Advisor, K Pharma Inc. |
Masato Yano, Ph.D.
| 2001 | M.S. Tokyo institute of Technology, Bioscience |
|---|---|
| 2005 | Ph.D. Physiology, Osaka University |
| 2004-2005 | Fellowship from Japan Society for the Promotion of Science |
| 2005-2006 | Post-doctoral fellow, Fellowship from Japan Society for the Promotion of Science |
| 2006 | Instructor, Center of Excellence Program, Keio University School of Medicine, Tokyo |
| 2006-2008 | Postdoctoral Associate, The Rockefeller University |
| 2008-2010 | Post-doctoral fellow, Fellowship from Japan Society for the Promotion of Science |
| 2010- | Postdoctoral Associate, The Rockefeller University |
| 2011-2014 | Assistant Professor, Keio University |
| 2014-present | Associate Professor, Niigata University |
| 2014-present | Visiting Associate Professor, Keio University |
| 2019-present | Scientific Advisor, K Pharma, Inc. |